179 related articles for article (PubMed ID: 26365710)
21. Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation.
Ferla S; Aboraia AS; Brancale A; Pepper CJ; Zhu J; Ochalek JT; DeLuca HF; Simons C
J Med Chem; 2014 Sep; 57(18):7702-15. PubMed ID: 25148392
[TBL] [Abstract][Full Text] [Related]
22. Prospective teratology of retinoic acid metabolic blocking agents (RAMBAs) and loss of CYP26 activity.
McCaffery P; Simons C
Curr Pharm Des; 2007; 13(29):3020-37. PubMed ID: 17979744
[TBL] [Abstract][Full Text] [Related]
23. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
[TBL] [Abstract][Full Text] [Related]
24. CYP26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid.
Langton S; Gudas LJ
Dev Biol; 2008 Mar; 315(2):331-54. PubMed ID: 18241852
[TBL] [Abstract][Full Text] [Related]
25. Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.
Topletz AR; Tripathy S; Foti RS; Shimshoni JA; Nelson WL; Isoherranen N
Mol Pharmacol; 2015; 87(3):430-41. PubMed ID: 25492813
[TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
27. Stereoselective formation and metabolism of 4-hydroxy-retinoic Acid enantiomers by cytochrome p450 enzymes.
Shimshoni JA; Roberts AG; Scian M; Topletz AR; Blankert SA; Halpert JR; Nelson WL; Isoherranen N
J Biol Chem; 2012 Dec; 287(50):42223-32. PubMed ID: 23071109
[TBL] [Abstract][Full Text] [Related]
28. CRABPs Alter
Yabut KCB; Isoherranen N
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565751
[TBL] [Abstract][Full Text] [Related]
29. Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs).
Mulvihill MJ; Kan JL; Beck P; Bittner M; Cesario C; Cooke A; Keane DM; Nigro AI; Nillson C; Smith V; Srebernak M; Sun FL; Vrkljan M; Winski SL; Castelhano AL; Emerson D; Gibson N
Bioorg Med Chem Lett; 2005 Mar; 15(6):1669-73. PubMed ID: 15745819
[TBL] [Abstract][Full Text] [Related]
30. Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1.
Awadalla MK; Alshammari TM; Eriksson LA; Saenz-Méndez P
Molecules; 2016 Mar; 21(3):351. PubMed ID: 26999080
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.
Nelson CH; Buttrick BR; Isoherranen N
Curr Top Med Chem; 2013; 13(12):1402-28. PubMed ID: 23688132
[TBL] [Abstract][Full Text] [Related]
32. Retinoic acid-metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy.
Han BC; Xia HF; Sun J; Yang Y; Peng JP
J Cell Physiol; 2010 May; 223(2):471-9. PubMed ID: 20112286
[TBL] [Abstract][Full Text] [Related]
33. Liarozole inhibits human epidermal retinoic acid 4-hydroxylase activity and differentially augments human skin responses to retinoic acid and retinol in vivo.
Kang S; Duell EA; Kim KJ; Voorhees JJ
J Invest Dermatol; 1996 Aug; 107(2):183-7. PubMed ID: 8757760
[TBL] [Abstract][Full Text] [Related]
34. Retinoic acid receptor agonist activity of naturally occurring diterpenes.
Tanabe H; Yasui T; Kotani H; Nagatsu A; Makishima M; Amagaya S; Inoue M
Bioorg Med Chem; 2014 Jun; 22(12):3204-12. PubMed ID: 24799257
[TBL] [Abstract][Full Text] [Related]
35. Structure-Activity Relationship and Mode-Of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors.
Walter I; Adam S; Gentilini MV; Kany AM; Brengel C; Thomann A; Sparwasser T; Köhnke J; Hartmann RW
ChemMedChem; 2021 Sep; 16(18):2786-2801. PubMed ID: 34010508
[TBL] [Abstract][Full Text] [Related]
36. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells.
Idres N; Marill J; Chabot GG
Biochem Pharmacol; 2005 Jun; 69(11):1595-601. PubMed ID: 15896339
[TBL] [Abstract][Full Text] [Related]
37. Discovery of biological evaluation of pyrazole/imidazole amides as mGlu5 receptor negative allosteric modulators.
Chae E; Shin YJ; Ryu EJ; Ji MK; Ryune Cho N; Lee KH; Jeong HJ; Kim SJ; Choi Y; Seok Oh K; Park CE; Soo Yoon Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):2134-9. PubMed ID: 23434029
[TBL] [Abstract][Full Text] [Related]
38. The discovery of new coding alleles of human CYP26A1 that are potentially defective in the metabolism of all-trans retinoic acid and their assessment in a recombinant cDNA expression system.
Lee SJ; Perera L; Coulter SJ; Mohrenweiser HW; Jetten A; Goldstein JA
Pharmacogenet Genomics; 2007 Mar; 17(3):169-80. PubMed ID: 17460545
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
40. Antimycobacterial activity of azepanobetulin and its derivative: In vitro, in vivo, ADMET and docking studies.
Kazakova O; Lopatina T; Giniyatullina G; Mioc M; Soica C
Bioorg Chem; 2020 Nov; 104():104209. PubMed ID: 32911190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
